NCT00277498 · Interventional trial
A 12-week, Randomized, Double-masked, Parallel Group Comparison of Evening Dosing With Xalacom in Subjects With Glaucoma
Overall registry status Completed
Phase 3
Conditions Ocular Hypertension, Open Angle Glaucoma
Delaware Valley sites
- Pfizer Investigational Site · Philadelphia, PA · Philadelphia County
- Pfizer Investigational Site · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory